Compliance & Legal
The third extension of pandemic-era telehealth flexibilities through the end of next year will give the agencies time to promulgate final regulations and providers time to comply, the agencies said.
In a letter to the FDA, members of Congress cite confusion over providers' deployment of clinical decision support software that is exempt from medical device regulations and call for clarity from its Center for Devices and Radiological Health.
The former GOP congressman from Georgia has served as a U.S. Navy chaplain and is a colonel in the Air Force Reserve. He would inherit a major EHR modernization initiative, currently paused but slated to restart in 2025, among other IT imperatives.
In discussing social determinants of health data utilization, Dr. Hilary Hatch, chief clinical officer at Phreesia, describes how analytics and patient engagement tools are streamlining workflows and helping providers respond to more patients in need.
Insured customers paid more for drugs than members of its Prescription Savings Club, lawsuit alleges.
New data elements related to social drivers of health, such as referrals to social services, improve standards-based information exchange with electronic health records, it says.
The medtech company says it is the only manufacturer of FDA-approved pulse oximeters to have reached an agreement in a lawsuit against many over the devices' notoriously higher rates of error for people with darker skin.
The electronic health record giant says that it did not violate federal law prohibiting unfair business practices when it raised concerns about certain patient data requests over the Carequality interoperability framework.
A new form of AI-powered fraud is posing risks to healthcare bottom lines. Medicomp CEO David Lareau describes what it is, how to fight it – and how to help cautious executives concerned with the double-edged sword of artificial intelligence.
